Target intelligence / Profile preview

Neuronal potassium channel (K+ channel) (K+ channel)

Target
K+ channel
Molecular classification
Ion channel, Potassium channel, Transmembrane protein
01

Overview

Neuronal potassium channels are a diverse superfamily of transmembrane proteins that selectively facilitate the efflux of potassium ions across the neuronal cell membrane. They are fundamental to the nervous system, where they maintain the resting membrane potential, modulate the duration and frequency of action potentials, and regulate neurotransmitter release (StatPearls, 2023). These channels are classified into several families, including voltage-gated (Kv), calcium-activated (KCa), inwardly rectifying (Kir), and two-pore domain (K2P) channels (PubMed, 2021). Dysfunction in these channels, often due to genetic mutations or autoimmune responses, is associated with a wide range of channelopathies such as epilepsy, episodic ataxia, and neuropathic pain (NIH, 2022). Consequently, they are major therapeutic targets; for instance, KCNQ (Kv7) channel openers like retigabine are used as anticonvulsants, while blockers like 4-aminopyridine are used to improve walking in multiple sclerosis patients (PubChem, 2024).

Other names
K+ channelVoltage-gated potassium channelCalcium-activated potassium channelInwardly rectifying potassium channelTwo-pore domain potassium channelK channelNeuronal K+ channel
02

Mechanism of action

Modulation of potassium ion conductance to regulate neuronal membrane potential and excitability, including activation of Kv7 channels to reduce firing and blockade of Kv1 channels to enhance conduction.

03

Biological functions

Signal transductionRegulation of membrane potentialAction potential repolarizationNeurotransmitter releaseNeuronal excitability
04

Disease associations

EpilepsyNeuropathic painAtaxiaNeurodegenerative diseaseMultiple sclerosisTinnitusPsychiatric disorder
05

Safety considerations

Cardiac arrhythmia (QT prolongation)DizzinessSomnolenceUrinary retentionVisual disturbancesSeizure risk (with blockers)Hypotension
06

Interacting drugs

Retigabine

9 more in the full profile.

07

Biomarkers

KCNQ2 genetic variantsKCNQ3 genetic variantsKCNA1 mutationsAnti-VGKC antibodiesEEG spike frequency

Beyond the preview

Go deeper on Neuronal potassium channel (K+ channel) (K+ channel).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuronal potassium channel (K+ channel) (K+ channel).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call